参与者中的虚拟代理人与甲基胺使用障碍:可接受性和可用性研究研究
Shuo Li1, Yue Wang1, Liyu Chen1
1Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Journal of telemedicine and telecare
|January 23, 2024
概括
虚拟代理 (VA) 在成治疗方面表现有前途,有物质使用障碍 (SUD) 的人愿意参与VA主导的心理治疗. 焦虑需求和慢性疾病等因素会影响人们对这种新的治疗方法的态度.
科学领域:
- 精神病学和行为科学
- 人与计算机的交互
- 数字健康数字健康
背景情况:
- 虚拟代理 (VA) 为成治疗提供了一个有前途的途径,但用户对VA主导心理治疗的态度仍未得到充分研究.
- 这种知识差距可能会阻碍对有物质使用障碍 (SUD) 的个人采用基于VA的干预措施.
研究的目的:
- 为了调查虚拟药物的可接受性和可用性,用于心理治疗,在个人中使用甲基胺使用障碍.
- 探索用户的偏好和参与VA主导心理治疗的意愿,考虑各种心理需求.
主要方法:
- 一组49名现有物质依赖的个人通过Echo应用程序接受了一次VA主导的心理治疗.
- 参与者填写了关于心理治疗偏好和愿意使用VA的问卷,随后进行了焦点小组采访.
主要成果:
- VA主导心理治疗的可接受性与传统面对面治疗相当,没有发现显著差异.
- 参与者表示愿意使用VA来预防复发,情绪问题,身体症状管理和社会/家庭恢复.
- 对VA主导心理治疗的态度受到焦虑治疗的需要,慢性体质疾病的存在和婚姻状况的显著影响.
结论:
- 患有SUD的个体表现出愿意并实际接受VA主导的心理治疗.
- 结果为改进基于VA的治疗工具提供了有价值的见解,以更好地满足用户的需求和偏好.
- 这项研究支持将虚拟代理纳入成治疗框架.
更多相关视频
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.2K
08:53Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
Published on: May 31, 2019
5.2K
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
476
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
476
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
